Indefinite Delivery Contract SPE2D223D0001

Award Date 10/5/22
Last Date to Order 10/4/27
Federal Agency
Medical Supply Chain
Awardee
Avkare LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) SPE2D222D0144 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The single-award contract has a ceiling value of $14,460,136.05 and a period of performance through May 3, 2027. Under this IDC, Avkare will manufacture and distribute a variety of pharmaceutical and medical products, including generic drugs such as cephalexin, prednisone,...
This Indefinite Delivery Contract (IDC) award from the Defense Logistics Agency (DLA) to Avkare LLC, a for-profit limited liability company based in Pulaski, Tennessee, has a ceiling value of $3,798,662.40 and a period of performance through April 26, 2025. The contract is for the manufacture and distribution of pharmaceutical and medical products, primarily consisting of generic medications such as cephalexin, prednisone, emtricitabine-tenofovir, primaquine phosphate, and...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $16,701,923.95 and a period of performance through December 7, 2026. The contract is for the manufacture and distribution of pharmaceutical and medical supplies, primarily generic medications such as cephalexin, prednisone, emtricitabine-tenofovir, primaquine phosphate, and...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Avkare LLC, a pharmaceutical and medical supply company based in Tennessee. The $62,144,789.65 contract has a period of performance through April 2025 and allows the DLA, Department of Veterans Affairs (VA), Indian Health Service (IHS), and Bureau of Prisons (BOP) to issue task orders for a variety of pharmaceutical and medical products. The original solicitation sought offers for a...
This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $4,897,608.76 and a period of performance through March 7, 2033. The contract aims to procure a wide range of pharmaceutical products and medical supplies to support the healthcare missions of various federal agencies, including the Department of Veterans Affairs...
This Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Avkare LLC, a pharmaceutical and medical supply company, has a total ceiling value of $10,373,182.60. The contract is for the manufacture and distribution of various pharmaceutical and medical products, including generic medications such as cephalexin, prednisone, sulfamethoxazole-trimethoprim, and primaquine phosphate tablets, as well as medical equipment and supplies like urinalysis testing materials and...
The Indefinite Delivery Contract (IDC) SPE2D220D0101 was awarded to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The $5,934,599.30 single-award contract was issued by the Defense Logistics Agency (DLA) to provide a national supply source for various pharmaceutical products, including generic medications such as cephalexin, prednisone, emtricitabine-tenofovir, primaquine phosphate, and sulfamethoxazole-trimethoprim. The contract has a base period of one...
The federal contract IDV award SPE2D225D0002 is an Indefinite Delivery Contract awarded by the Defense Logistics Agency (DLA) to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract has a ceiling value of $8,147,325.32 and a period of performance through January 30, 2025. The contract provides for the delivery of a variety of generic medications and medical supplies to federal agencies including the Department of Defense (DoD), Department of...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian federal agency, to Avkare LLC, a pharmaceutical and medical supply company, to provide a wide range of pharmaceutical products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a total ceiling value of $12,991,472.85 and a period of performance from March 16, 2020 to March 15, 2025. It was awarded as a...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract is for the supply of Abiraterone Acetate 250mg Tablets to the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract has a one-year base period with four one-year option periods, for a total ceiling value of...

The Indefinite Delivery Contract (IDC) SPE2D223D0001 was awarded by the Defense Logistics Agency (DLA) to Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The single-award contract has a ceiling value of $43,144,442.15 and a period of performance through October 4, 2027.

The contract aims to establish a national supply source for Estradiol Tablets in 8 and 18 count packs for the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. This is an unrestricted commercial item acquisition under FAR Part 12, with no set-asides used. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year option periods. Annual usage estimates will be provided in the solicitation schedule, which is expected to be issued by the DLA in June 2022. Avkare is a for-profit limited liability company that has held several significant IDC awards with federal agencies, demonstrating its capability to meet government healthcare procurement requirements.

Generated 3/20/25, 9:59 AM